What is this webinar about?
The Covid-19 pandemic has forced the pharmaceutical and medical device industries to explore methods beyond the traditional on-site monitoring and auditing of clinical trial sites. It has enabled companies to leverage both existing technologies and quickly adopt new methodologies to ensure data integrity and patient safety.
With these changes, companies are able to identify opportunities for both increased quality and efficiencies in their clinical trials.
In this webinar, we discuss:
- Opportunities and the challenges of the “new normal” in the management and oversight of clinical trials
- Insights into how we think technology will evolve in the future to better support new risk-based approaches to oversight
- AI's growing role in clinical trial oversight